These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36181729)
1. Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters. Khajebishak Y; Faghfouri AH; Soleimani A; Madani S; Payahoo L Horm Mol Biol Clin Investig; 2023 Jun; 44(2):127-135. PubMed ID: 36181729 [TBL] [Abstract][Full Text] [Related]
2. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity. Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052 [TBL] [Abstract][Full Text] [Related]
3. Low serum levels of meteorin-like/subfatin: an indicator of diabetes mellitus and insulin resistance? Onalan E; Cavlı C; Dogan Y; Onalan E; Gozel N; Buran I; Yakar B; Donder E Endokrynol Pol; 2020; 71(5):397-403. PubMed ID: 32598020 [TBL] [Abstract][Full Text] [Related]
4. Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance. Wang K; Li F; Wang C; Deng Y; Cao Z; Cui Y; Xu K; Ln P; Sun Y Med Sci Monit; 2019 Mar; 25():2337-2343. PubMed ID: 30928991 [TBL] [Abstract][Full Text] [Related]
5. Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study. Zhou C; Zeng J; Gao X; Chen D; Zhu Q; Feng B; Song J PeerJ; 2024; 12():e18264. PubMed ID: 39421410 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of irisin and Meteorin-like protein in PCOS and its correlation with metabolic parameters. Paczkowska K; Sobczuk J; Zawadzka K; Jędrzejuk D; Zembska A; Konieczny J; Kaszubkiewicz-Wardęga D; Bolanowski M; Daroszewski J Endokrynol Pol; 2024; 75(2):199-206. PubMed ID: 38646985 [TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin. AlKhairi I; Cherian P; Abu-Farha M; Madhoun AA; Nizam R; Melhem M; Jamal M; Al-Sabah S; Ali H; Tuomilehto J; Al-Mulla F; Abubaker J Cells; 2019 Oct; 8(10):. PubMed ID: 31635130 [TBL] [Abstract][Full Text] [Related]
8. Serum Metrnl Level is Correlated with Insulin Resistance, But Not with β-Cell Function in Type 2 Diabetics. Wang C; Pan Y; Song J; Sun Y; Li H; Chen L; Hou X Med Sci Monit; 2019 Nov; 25():8968-8974. PubMed ID: 31766048 [TBL] [Abstract][Full Text] [Related]
9. Meteorin-like Protein and Asprosin Levels in Children and Adolescents with Obesity and Their Relationship with Insulin Resistance and Metabolic Syndrome. Moradi N; Fadaei R; Roozbehkia M; Nourbakhsh M; Nourbakhsh M; Razzaghy-Azar M; Larijani B Lab Med; 2023 Sep; 54(5):457-463. PubMed ID: 36762837 [TBL] [Abstract][Full Text] [Related]
10. Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis. El-Ashmawy HM; Selim FO; Hosny TAM; Almassry HN Diabetes Res Clin Pract; 2019 Apr; 150():57-63. PubMed ID: 30825562 [TBL] [Abstract][Full Text] [Related]
11. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. Dadmanesh M; Aghajani H; Fadaei R; Ghorban K PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581 [TBL] [Abstract][Full Text] [Related]
12. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of β cell function in a Chinese population with different glucose tolerance status. Zhou M; Zhu L; Cui X; Feng L; Zhao X; He S; Ping F; Li W; Li Y Lipids Health Dis; 2016 Jun; 15():104. PubMed ID: 27267043 [TBL] [Abstract][Full Text] [Related]
13. The Levels of Serum Irisin as a Predictor of Insulin Resistance in Han Chinese Adults with Metabolically Healthy Obesity. Liu BW; Yin FZ; Qi XM; Fan DM; Zhang Y Clin Lab; 2017 May; 63(5):881-886. PubMed ID: 28627815 [TBL] [Abstract][Full Text] [Related]
15. Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile. Ding X; Chang X; Wang J; Bian N; An Y; Wang G; Liu J Front Endocrinol (Lausanne); 2022; 13():938341. PubMed ID: 36133314 [TBL] [Abstract][Full Text] [Related]
16. Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial. Werida RH; Ramzy A; Ebrahim YN; Helmy MW BMC Endocr Disord; 2023 Nov; 23(1):259. PubMed ID: 38001474 [TBL] [Abstract][Full Text] [Related]
17. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings. Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial. Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527 [TBL] [Abstract][Full Text] [Related]
19. Two Important Players for Type 2 Diabetes Mellitus: Metrnl and Asprosin. Timurkaan M; Timurkaan ES Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125157 [TBL] [Abstract][Full Text] [Related]
20. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial. Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]